IP Library Granted Patent US 9,023,850
Granted Patent B2
US 9,023,850 · App. 13/878,261 · Granted May 5, 2015

Nematocidal sulfonamides

Inventors: George Philip Lahm (Wilmington, DE); Thomas Francis Pahutski, Jr. (Elkton, MD)
Assignee: E I du Pont de Nemours and Company
A01N43/90C07D487/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,023,850
App. No.
13/878,261
Granted
May 5, 2015
Kind
B2
Abstract

Disclosed are compounds of Formula 1, N-oxides, and salts thereof, wherein Z is O or S; A 1 , A 2 , A 3 and A 4 are independently N or CR 1 , provided that only one of A 1 , A 2 , A 3 and A 4 is N; and R 1 , R 2 , R 3 and Q are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling a parasitic nematode comprising contacting the parasitic nematode or its environment with a biologically effective amount of a compound or a composition of the invention.

Claims (51)

1. A compound selected from Formula 1, an N-oxide, or a salt thereof,

wherein

Z is O or S;

A 1 , A 3 and A 4 are independently N or CR 1 , provided that only one of A 1 , A 3 and A 4 must be N in each compound;

A 2 is C-CF 3 ;

each R 1 is independently H, halogen, cyano, nitro, OR 4 , NR 5 R 6 , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl, C 3 -C 7 cycloalkyl, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 or S(O) 2 NR 11 R 12 ; or phenyl, naphthalenyl or a 5- or 6-membered heteroaromatic ring, each optionally substituted with 1 to 5 substituents independently selected from the group consisting of halogen, cyano, nitro, OR 4 , NR 5 R 6 , C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 1 -C 4 haloalkyl, C 2 -C 4 haloalkenyl, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 and S(O) 2 NR 11 R 12 ;

R 2 is H, halogen, cyano, nitro, OR 4 , NR 5 R 6 , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl, C 3 -C 7 cycloalkyl, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 or S(O) 2 NR 11 R 12 ; or phenyl, naphthalenyl or a 5- or 6-membered heteroaromatic ring, each optionally substituted with 1 to 5 substituents independently selected from the group consisting of halogen, cyano, nitro, OR 4 , NR 5 R 6 , C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 1 -C 4 haloalkyl, C 2 -C 4 haloalkenyl, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 and S(O) 2 NR 11 R 12 ;

R 3 is H, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 or S(O) 2 NR 11 R 12 ; or C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 7 cycloalkyl, C 4 -C 8 cycloalkylalkyl or C 5 -C 7 cycloalkenyl, each optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, cyano, nitro, OR 4 , NR 5 R 6 , C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 and S(O) 2 NR 11 R 12 ; or C 1 -C 6 alkyl substituted with 1 or 2 substituents independently selected from the group consisting of phenyl or a 5- or 6-membered heteroaromatic ring, each optionally substituted with 1 to 5 substituents independently selected from the group consisting of halogen, cyano, nitro, OR 4 , NR 5 R 6 , C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 1 -C 4 haloalkyl, C 2 -C 4 haloalkenyl, C 2 -C 6 alkoxyalkyl, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 and S(O) 2 NR 11 R 12 ;

Q is phenyl, naphthalenyl, a 5- or 6-membered heteroaromatic ring or an 8- to 10-membered aromatic bicyclic ring system, each optionally substituted with 1 to 5 substituents independently selected from the group consisting of halogen, cyano, nitro, OR 4 , NR 5 R 6 , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl, C(X)R 7 , C(O)OR 8 , C(X)NR 11 R 12 , S(O) m R 9 , S(O) 2 NR 11 R 12 , OC(O)R 7 , OC(O)OR 8 , OC(O)NR 11 R 12 , OS(O) 2 R 9 , OS(O) 2 NR 11 R 12 , N(R 10 )C(O)R 7 , N(R 10 )C(O)NR 11 R 12 , N(R 10 )S(O) 2 R 9 , N(R 10 )S(O) 2 NR 11 R 12 and R 14 ;

each X is independently O or S;

each R 4 is independently H, NR 5a R 6a , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 or S(O) m R 9 ; or C 3 -C 7 cycloalkyl, C 4 -C 8 cycloalkylalkyl, C 6 -C 14 cycloalkylcycloalkyl or C 5 -C 7 cycloalkenyl, each optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, OR 4a and S(O) m R 9a ; or phenyl optionally substituted with 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 1 -C 4 haloalkyl, C 2 -C 4 haloalkenyl, C(X)R 7a , C(O)OR 8a , C(O)NR 11 R 12 , OR 4a , C 2 -C 6 alkoxyalkyl, S(O) m R 9a , S(O) 2 NR 11 R 12 , NR 5a R 6a , OC(O)R 7a and N(R 10 )C(O)R 7a ;

each R 4a is independently H, C 1 -C 6 alkyl or C 1 -C 6 haloalkyl;

each R 5 is independently H, NR 5a R 6a , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 or S(O) 2 NR 11 R 12 ; or C 3 -C 7 cycloalkyl, C 4 -C 8 cycloalkylalkyl, C 6 -C 14 cycloalkylcycloalkyl or C 5 -C 7 cycloalkenyl, each optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, OR 4a and S(O) m R 9a ; or phenyl optionally substituted with 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 1 -C 4 haloalkyl, C 2 -C 4 haloalkenyl, C(X)R 7a , C(O)OR 8a , C(O)NR 11 R 12 , OR 4a , C 2 -C 6 alkoxyalkyl, S(O) m R 9a , S(O) 2 NR 11 R 12 , NR 5a R 6a , OC(O)R 7a and N(R 10 )C(O)R 7a ;

each R 5a is independently H or C 1 -C 6 alkyl;

each R 6 is independently H, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl, C 3 -C 7 cycloalkyl, C(X)R 7a , C(O)OR 8a , C(O)NR 11 R 12 , S(O) m R 9a or S(O) 2 NR 11 R 12 ;

each R 6a is independently H, C 1 -C 6 alkyl, C(O)R 13 or C(O)OR 13 ;

each R 7 is independently H, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl or C 2 -C 6 haloalkynyl; or C 3 -C 7 cycloalkyl, C 4 -C 8 cycloalkylalkyl, C 6 -C 14 cycloalkylcycloalkyl or C 5 -C 7 cycloalkenyl, each optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, OR 4a and S(O) m R 9a ; or phenyl optionally substituted with 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 1 -C 4 haloalkyl, C 2 -C 4 haloalkenyl, C(X)R 7a , C(O)OR 8a , C(O)NR 11 R 12 , OR 4a , C 2 -C 6 alkoxyalkyl, S(O) m R 9a , S(O) 2 NR 11 R 12 , NR 5a R 6a , OC(O)R 7a and N(R 10 )C(O)R 7a ;

each R 7a is independently C 1 -C 6 alkyl or C 1 -C 6 haloalkyl;

each R 8 is independently H, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl or C 2 -C 6 haloalkynyl; or C 3 -C 7 cycloalkyl, C 4 -C 8 cycloalkylalkyl, C 6 -C 14 cycloalkylcycloalkyl or C 5 -C 7 cycloalkenyl, each optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, OR 4a and S(O) m R 9a ; or phenyl optionally substituted with 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 1 -C 4 haloalkyl, C 2 -C 4 haloalkenyl, C(X)R 7a , C(O)OR 8a , C(O)NR 11 R 12 , OR 4a , C 2 -C 6 alkoxyalkyl, S(O) m R 9a , S(O) 2 NR 11 R 12 , NR 5a R 6a , OC(O)R 7a and N(R 10 )C(O)R 7a ;

each R 8a is independently C 1 -C 6 alkyl or C 1 -C 6 haloalkyl;

each R 9 is independently H, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl or C 2 -C 6 haloalkynyl; or C 3 -C 7 cycloalkyl, C 4 -C 8 cycloalkylalkyl, C 6 -C 14 cycloalkylcycloalkyl or C 5 -C 7 cycloalkenyl, each optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, OR 4a and S(O) m R 9a ; or phenyl optionally substituted with 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 1 -C 4 haloalkyl, C 2 -C 4 haloalkenyl, C(X)R 7a , C(O)OR 8a , C(O)NR 11 R 12 , OR 4a , C 2 -C 6 alkoxyalkyl, S(O) m R 9a , S(O) 2 NR 11 R 12 , NR 5a R 6a , OC(O)R 7a and N(R 10 )C(O)R 7a ;

each R 9a is independently C 1 -C 6 alkyl or C 1 -C 6 haloalkyl;

each R 10 is independently H, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl, C 3 -C 7 cycloalkyl, C(X)R 7a , C(O)OR 8a , C(O)NR 11 R 12 , S(O) m R 9a or S(O) 2 NR 11 R 12 ;

each R 11 is independently H, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl or C 2 -C 6 haloalkynyl; or C 3 -C 7 cycloalkyl, C 4 -C 8 cycloalkylalkyl, C 6 -C 14 cycloalkylcycloalkyl or C 5 -C 7 cycloalkenyl, each optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, OR 4a and S(O) m R 9a ; or phenyl optionally substituted with 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 1 -C 4 haloalkyl, C 2 -C 4 haloalkenyl, C(X)R 7a , C(O)OR 8a , C(O)NR 11a R 12 , OR 4a , C 2 -C 6 alkoxyalkyl, S(O) m R 9a , S(O) 2 NR 11a R 12 , NR 5a R 6a , OC(O)R 7a and N(R 10 )C(O)R 7a ;

each R 11a is independently H, C 1 -C 6 alkyl, C 2 -C 6 alkenyl or C 2 -C 6 alkynyl;

each R 12 is independently H, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl or C 3 -C 7 cycloalkyl;

each R 13 is independently H, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl or C 2 -C 6 haloalkynyl; or C 3 -C 7 cycloalkyl, C 4 -C 8 cycloalkylalkyl, C 6 -C 14 cycloalkylcycloalkyl or C 5 -C 7 cycloalkenyl, each optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, OR 4a and S(O) m R 9a ;

each R 14 is independently C 3 -C 7 cycloalkyl, C 4 -C 8 cycloalkylalkyl, C 6 -C 14 cycloalkylcycloalkyl or C 5 -C 7 cycloalkenyl, each optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, OR 4a and S(O) m R 9a ; or C 1 -C 6 alkyl, C 2 -C 6 alkenyl or C 2 -C 6 alkynyl, each substituted with 1 to 4 substituents independently selected from the group consisting of cyano, nitro, OR 4 , NR 5 R 6 , C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 and S(O) 2 NR 11 R 12 ; or phenyl, naphthalenyl or a 5- or 6-membered heteroaromatic ring, each optionally substituted with 1 to 5 substituents independently selected from the group consisting of halogen, cyano, nitro, OR 4 , NR 5 R 6 , C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 1 -C 4 haloalkyl, C 2 -C 4 haloalkenyl, C 2 -C 6 alkoxyalkyl, C(X)R 7 , C(O)OR 8 , C(O)NR 11 R 12 , S(O) m R 9 , S(O) 2 NR 11 R 12 , OC(O)R 7a and N(R 10 )C(O)R 7a ; and

each m is independently 0, 1 or 2.

2. A compound of claim 1 wherein:

Z is O; and

Q is phenyl or a 5- or 6-membered heteroaromatic ring, each optionally substituted with 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, OR 4 , NR 5 R 6 , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl, C(X)R 7 , C(O)OR 8 , C(X)NR 11 R 12 , S(O) m R 9 , S(O) 2 NR 11 R 12 , OC(O)R 7 and N(R 10 )C(O)R 7 .

3. A compound of claim 2 wherein:

Q is phenyl, pyridinyl, pyrazolyl, oxazolyl, thiazolyl, isoxazolyl, isothiazolyl, furanyl or thienyl, each optionally substituted with 1 to 3 substituents independently selected from the group consisting of halogen, cyano, nitro, OR 4 , NR 5 R 6 , C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl, C(X)R 7 , C(O)OR 8 , C(X)NR 11 R 12 , S(O) m R 9 , S(O) 2 NR 11 R 12 , OC(O)R 7 and N(R 10 )C(O)R 7 .

4. A compound of claim 2 or 3 wherein:

each R 1 is independently halogen, cyano, nitro, OR 4 , C 1 -C 6 alkyl or C 1 -C 6 haloalkyl;

R 2 is H, halogen or C 1 -C 6 alkyl; and

R 3 is H, C(X)R 7 , C(O)OR 8 or S(O) m R 9 ; or C 1 -C 6 alkyl optionally substituted with 1 to 4 substituents independently selected from halogen.

5. A compound of claim 1 that is selected from the group consisting of:

N-[(2-chloro-5-methoxyphenyl)sulfonyl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine-2-carboxamide;

and

N-[[2-chloro-5-(trifluoromethyl)phenyl]sulfonyl]-6-(trifluoromethyl)imidazo[1,2-a]pyrimidine-2-carboxamide.

6. A composition comprising a compound of claim 1 and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.

7. The composition of claim 6 wherein said composition further comprises at least one additional biologically active compound or agent.

8. The composition of claim 7 wherein the at least one additional biologically active compound or agent is selected from the group consisting of abamectin, acephate, acequinocyl, acetamiprid, acrinathrin, amidoflumet, amitraz, avermectin, azadirachtin, azinphos-methyl, bifenthrin, bifenazate, bistrifluoron, borate, buprofezin, carbaryl, carbofuran, cartap, carzol, chlorantraniliprole, chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clofentezin, clothianidin, cyantraniliprole, cyflumetofen, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, dieldrin, diflubenzuron, dimefluthrin, dimehypo, dimethoate, dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, etofenprox, etoxazole, fenbutatin oxide, fenothiocarb, fenoxycarb, fenpropathrin, fenvalerate, fipronil, flonicamid, flubendiamide, flucythrinate, flufenerim, flufenoxuron, fluvalinate, tau-fluvalinate, fonophos, formetanate, fosthiazate, halofenozide, hexaflumuron, hexythiazox, hydramethylnon, imidacloprid, indoxacarb, insecticidal soaps, isofenphos, lufenuron, malathion, metaflumizone, metaldehyde, methamidophos, methidathion, methiodicarb, methomyl, methoprene, methoxychlor, metofluthrin, monocrotophos, methoxyfenozide, nitenpyram, nithiazine, novaluron, noviflumuron, oxamyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, profluthrin, propargite, protrifenbute, pymetrozine, pyrafluprole, pyrethrin, pyridaben, pyridalyl, pyrifluquinazon, pyriprole, pyriproxyfen, rotenone, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen, spirotetramat, sulprofos, tebufenozide, tebufenpyrad, teflubenzuron, tefluthrin, terbufos, tetrachlorvinphos, tetramethrin, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tolfenpyrad, tralomethrin, triazamate, trichlorfon, triflumuron, all strains of Bacillus thuringiensis , entomopathogenic bacteria, all strains of Nucleo polyhydrosis viruses, entomopathogenic viruses and entomopathogenic fungi.

9. The composition of claim 8 wherein the at least one additional biologically active compound or agent is selected from the group consisting of abamectin, acetamiprid, acrinathrin, amitraz, avermectin, azadirachtin, bifenthrin, buprofezin, carbaryl, cartap, chlorantraniliprole, chlorfenapyr, chlorpyrifos, clothianidin, cyantraniliprole, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, cyromazine, deltamethrin, dieldrin, dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, etofenprox, etoxazole, fenothiocarb, fenoxycarb, fenvalerate, fipronil, flonicamid, flubendiamide, flufenoxuron, fluvalinate, formetanate, hexaflumuron, hydramethylnon, imidacloprid, indoxacarb, lufenuron, metaflumizone, methiodicarb, methomyl, methoprene, methoxyfenozide, nitenpyram, nithiazine, novaluron, oxamyl, pymetrozine, pyrethrin, pyridaben, pyridalyl, pyriproxyfen, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen, spirotetramat, tebufenozide, tetramethrin, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tralomethrin, triazamate, triflumuron, all strains of Bacillus thuringiensis and all strains of Nucleo polyhydrosis viruses.

10. A method for controlling a parasitic nematode comprising contacting the parasitic nematode or its environment with a biologically effective amount of a compound of claim 1 .

11. The method of claim 10 wherein the environment is a plant.

12. The method of claim 10 wherein the environment is a seed.

13. The method of claim 12 wherein the seed is coated with the compound of Formula 1, an N-oxide or salt thereof, formulated as a composition comprising a film former or adhesive agent.

14. A treated seed comprising a compound of claim 1 in an amount of from about 0.0001 to 1% by weight of the seed before treatment.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Nov 29, 2022
From: E.I. DU PONT DE NEMOURS AND COMPANY
To: CORTEVA AGRISCIENCE LLC
Reel/Frame 063141/0155 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2013
From: LAHM, GEORGE PHILIP; PAHUTSKI, THOMAS FRANCIS, JR
To: E.I. DUPONT DE NEMOURS AND COMPANY
Reel/Frame 030175/0197 →
Continuity (2)
Provisional Application 61394080 · Oct 18, 2010
Related Publication 20130190172A1 · Jul 25, 2013